Dr Lim Chong Wei, an endocrinology, diabetes and internal medicine specialist at Sunway Medical Centre, clarified that semaglutide was originally approved as a weekly injection for Type 2 diabetes, typically combined with the right diet and exercise
If you became eligible for Medicare before January 1, 2020, you can enroll in Plan F and avoid the Part B deductible entirely-Plan F covers it completely according to Medicare.gov
In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Regular screening for mood disorders, monitoring behavioral changes, and involving trusted family members can help detect concerns early